ClinicalTrials.Veeva

Menu

Prevalence of Hepatitis B Infection in the Galilee Region, Israel

W

Western Galilee Hospital-Nahariya

Status

Withdrawn

Conditions

Hepatitis B

Study type

Observational

Funder types

Other

Identifiers

NCT01645007
0025-12-NHR

Details and patient eligibility

About

Primary Aims:

  1. Evaluate HBV (Hepatitis B Virus) infection prevalence among Druze in the Galilee.
  2. Educate the population in order to reduce transmission
  3. Increase awareness among primary care providers

Secondary Aims:

  1. Identify chronic HBV infected patients who need to be followed and treated,
  2. Identify HBV infected women in a childbearing age
  3. Identify non immunized individuals and recommend vaccination
  4. Identify previously vaccinated individuals who are not immunized
  5. Identify previously vaccinated individuals who became infected

Study Design:

Study population is targeted to native Israeli Druze. We aim for evaluating up to 20,000 people from Druze communities in the Galilee area

This work will be divided into three sections:

  1. Increasing awareness: lectures and local events will be taken place in the communities. Written information will be given and primary care-providers mainly family doctors, nurses and obstetric surgeons will be involved.

  2. All participants, upon signing a consent will:

    • Fill up a questioner
    • Checked for weight, height and waist circumflex
    • Have a blood sample taken
  3. Results and recommendations will be forwarded to all participants

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All consent adults who are 18 year old or older

Exclusion criteria

  • Individuals younger than 18 year old
  • Individuals who cannot or will not sign consent

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems